InspireMD Inc

NSPR

Company Profile

  • Business description

    InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

  • Contact

    6303 Waterford District Drive
    Suite 215
    MiamiFL33126
    USA

    T: +1 888 776-6804

    https://www.inspiremd.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    127

Stocks News & Analysis

stocks

Fair value upgrade for this ASX income player

Headwinds in listed energy stocks likely to have passed
stocks

The SpaceX IPO and the Elon Musk factor

Potential investors should remember that the company’s controlling shareholder can move markets with a few words.
stocks

The ASX’s most shorted stocks in 2026

What we can and can’t learn from the top 20 most shorted ASX shares.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,657.502.200.03%
CAC 407,748.8846.930.61%
DAX 4022,435.79135.040.61%
Dow JONES (US)45,438.75272.110.60%
FTSE 10010,103.78136.431.37%
HKSE24,750.79201.09-0.81%
NASDAQ20,952.364.010.02%
Nikkei 22551,885.851,487.22-2.79%
NZX 50 Index12,748.92186.47-1.44%
S&P 5006,385.6516.800.26%
S&P/ASX 2008,461.000.100.00%
SSE Composite Index3,923.299.560.24%

Market Movers